Mapping of rat hippocampal neurons with NeuN after ischemia/reperfusion and Ginkgo biloba extract (EGb 761) pretreatment

Cellular and Molecular Neurobiology

Volumn 26, Issue 7-8, 2006, Pages 1193-1204

  Domoráková, Iveta ^a   Burda, Jozef ^b   Mechírová, Eva ^a   Feriková, Marianna ^a  

^a P J AFÁRIK UNIVERSITY   (Slovakia)

^b INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

Brain; CA1; GFAP; Ginkgo biloba extract (EGb 761); Hippocampus; Ischemia; NeuN; Rat

Indexed keywords

GINKGO BILOBA EXTRACT; GLIAL FIBRILLARY ACIDIC PROTEIN; HEMATOXYLIN; NUCLEAR PROTEIN; PROTEIN NEUN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; ASTROCYTE; BRAIN ISCHEMIA; BRAIN MAPPING; BRAIN NERVE CELL; BRAIN REGION; CAROTID ARTERY OBSTRUCTION; CELL COUNT; CELL LABELING; CELL SURVIVAL; CEREBELLUM MOLECULAR LAYER; CONTROLLED STUDY; DRUG EFFICACY; GLIA CELL; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NERVE CELL NECROSIS; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; PYRAMIDAL NERVE CELL; RAT; REPERFUSION; STRATUM LACUNOSUM; STRATUM ORIENS; TRANSIENT ISCHEMIC ATTACK; TREATMENT RESPONSE; WISTAR RAT;

ANIMALS; ASTROCYTES; BRAIN MAPPING; GINKGO BILOBA; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; NERVE TISSUE PROTEINS; NEUROPROTECTIVE AGENTS; NUCLEAR PROTEINS; PLANT EXTRACTS; PYRAMIDAL CELLS; RATS; RATS, WISTAR; REPERFUSION INJURY;

GINKGO BILOBA; RATTUS NORVEGICUS;

EID: 33845549354     PISSN: 02724340     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10571-006-9080-6     Document Type: Article

References (43)

1. Bodsch, W., Takahashi, K., Barbier, A., Ophoff, B. G., and Hossmann, K. A. (1985). Cerebral protein synthesis and ischemia. Prog. Brain Res. 63:197-210.
2. Burda, J., Martin, M. E., Garcia, A., Alcazar, A., Fando, J. L., and Salinas, M. (1994). Phosphorylation of the alpha subunit of initiation factor 2 correlates with the inhibition of translation following transient cerebral ischemia in the rat. Biochem. J. 302:335-338.
3. Calapai, G., Crupi, A., Firenzuoli, F., Marciano, M. C., Squadrito, F., Inferrera, G., Parisi, G., Rizzo, A., Crisafulli, C., Fiore, A., and Caputi, A. P. (2000). Neuroprotective effect of Ginkgo biloba extract in brain ischemia are mediated by inhibition of nitric oxide synthesis. Life Sci. 67:2673-2683.
4. Chandrasekaran, K., Mehrabian, Z., Spinnewyn, B., Drieu, K., and Fiskum, G. (2001). Neuroprotective effects of bilobalide, a component of the Ginkgo biloba extract (EGb 761), in gerbil global brain ischemia. Brain Res. 922:282-292.
5. Chen, Y., and Swanson, R. A. (2003). Astrocytes and brain injury. J. Cereb. Blood Flow Metab. 23:137-149.
6. Clark, W. M., Rinker, L. G., Lessov, N. S., Lowery, S. L., and Cipolla, M. J. (2001). Efficacy of antioxidant therapies in transient focal ischemia in mice. Stroke 32:1000-1004.
7. D'Ambrosio, A. L., Pinsky, D. J., and Connolly, E. S. (2001). The role of a complement cascade in ischemia/reperfusion injury: Implication for neuroprotection. Mol. Med. 7:367-382.
8. DeFeudis, F. V. (1998). Ginkgo biloba extract (EGb 761), Ullstein Medical, Wiesbaden, pp. 1-401.
9. Drieu, K. (1986). Preparation and definition of Ginkgo biloba extract. Presse Med. 15:1455-1457.
10. +: Implications of neurodegeneration. J. Neurochem. 63:584-591.
11. Feriková, M., Mechírová, E., and Domoráková, I. (2004). Demonstration of ubiquitin following ischemia and reperfusion of spinal cord neurons in the rabbit. Acta Vet. Brno 73:51-54.
12. Fiskum, G., Murphy, A. N., and Beal, M. F. (1999). Mitochondria in neurodegeneration: Acute ischemia and chronic neurodegenerative diseases. J. Cereb. Blood Flow Metab. 19:351-369.
13. Gdovinová, Z. (2001).Tanakan v liečbe neurologických ochorení. Slov. Lekár 11:12-15.
14. Hrehorovská, M., Burda, J., Domoráková, I., and Mechírová, E. (2004). Effect of Tanakan on postischemic activity of protein synthesis machinery in the rat brain. Gen. Physiol. Biophys. 23:457-465.
15. Joyeux, M., Lobstein, A., Anton, A., and Mortier, F. (1995). Comparative antilipid peroxidant, antinecrotic and scavenging properties of terpenes and biflavones from Ginkgo biloba. Planta Med. 61:126-129.
16. Kim, Y. S., Pyo, M. K., Park, K. M., Park, P. H., Hahn, B. S., Wu, S. J., and Yun-Choi, H. S. (1998). Antiplatelet and antithrombotic effects of a combination of ticlopidine and Ginkgo biloba extract (EGb 761). Thromb. Res. 91:33-38.
17. Kirino, T. (1982). Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res. 239:57-69.
18. Leis, J., Bekar, L., and Walz, W. (2005). Potassium homeostasis in the ischemic brain. Glia 50:407-416.
19. Lo, E. H., Dalkara, T., and Moskowitz, M. A. (2003). Mechanisms, challenges and opportunities in stroke. Nat. Rev. Neurosci. 4:399-415.
20. Marcocci, L., Packer, L., Droy-Lefaix, M. T., Sekaki, A., and Gardes-Albert, M. (1994). Antioxidant action of Ginkgo biloba extract EGb 761. Methods Enzymol. 234:462-475.
21. Matthias, K., Kirchhoff, F., Seifert, G., Huttmann, K., Matyash, M., Kettenmann, H., and Steinhauser, C. (2003). Segregated expression of AMPA-type glutamate receptors and glutamate transporters defines distinct astrocyte population in the mouse hippocampus. J. Neurosci. 23:1750-1758.
22. Mechírová, E., and Domoráková, I. (2002). NADPH-diaphorase activity in the spinal cord after ischemic injury and the effects of pretreatment with Ginkgo biloba extract (EGb 761). Acta Histochem. 104(4):427-430.
23. Morin, D., Hauet, T., Spedding, M., and Tillement, J. P. (2001). Mitochondria as a target for antiischemic drugs. Adv. Drug Deliv. Rev. 49:151-174.
24. Nishino, K., and Nowak, T. S. Jr. (2004). Time course and cellular distribution of hsp27 and hsp72 stress protein expression in a quantitative gerbil model of ischemic injury and tolerance: Thresholds for hsp72 induction and hilar lesioning in the contex of ischemic preconditioning. J. Cereb. Blood Flow Metab. 24:167-178.
25. Oyama, Y., Chikahisa, L., Ueha, T., Kanemaru, K., and Noda, K. (1996). Ginkgo biloba extract protects brain neurons against oxidative stress induced by hydrogen peroxide. Brain Res. 712:349-352.
26. Pascual, J. M., Carceller, F., Roda, J. M., and Cerdan, S. (1998). Glutamate, glutamine, and GABA as substrates for the neuronal and glial compartments after focal cerebral ischemia in rats. Stroke 29:1048-1056.
27. Peng, H., Li, Y. F., and Sun, S. G. (2003). Effects of Ginkgo biloba extract on acute cerebral ischemia in rats analyzed by magnetic resonance spectroscopy. Acta Pharmacol. Sin. 24:467-471.
28. Petito, C. K., and Babiak, T. (1982). Early proliferative changes in astrocytes in postischemic noninfarcted rat brain. Ann. Neurol. 11:510-518.
29. Petito, C. K., Feldmann, E., Pulsinelli, W. A., and Plum, F. (1987). Delayed hippocampal damage in humans following cardiorespiratory arrest. Neurology 37:1281-1286.
30. Pietri, S., Maurelli, E., Drieu, K., and Culcasi, M. (1997). Cardioprotective and anti- oxidant effects of the terpenoid constituents of Ginkgo biloba extract (EGb 761). J. Mol. Cell. Cardiol. 29:733-742.
31. Puisieux, F., Deplanque, D., Bulckaen, H., Maboudou, P., Gelé, P., Lhermitte, M., Lebuffe, G., and Bordet, R. (2004). Brain ischemic preconditioning is abolished by antioxidant drugs but does not up-regulate superoxide dismutase and glutathion peroxidase. Brain Res. 1027:30-37.
32. Pulsinelli, W. A. (1985). Selective neuronal vulnerability: Morphological and molecular characteristics. Prog. Brain Res. 63:29-37.
33. Pulsinelli, W. A., and Brierley, J. B. (1979). A new model of bilateral hemispheric ischemia in the unanesthetized rat. Stroke 10:267-272.
34. Pulsinelli, W. A., Brierley, J. B., and Plum, F. (1982a). Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann. Neurol. 11:491-498.
35. Pulsinelli, W. A., Levy, D. E., and Duffy, T. E. (1982b). Regional cerebral blood flow and glucose metabolism following transient forebrain ischemia. Ann. Neurol. 11:499-509.
36. Roy, S., Kobushi, H., Sen, C. K., Gohil, K., Droix-Lefaix, M. T., and Packer, L. (1998). Ginkgo biloba extract (EGb 761): Antioxidant properties and regulation of gene expression. In Packer, L., and Christen, Y. (eds.), Advances in Ginkgo Biloba Extract Research, Ginkgo biloba Extract (EGb 761): Lessons from Cell Biology, Vol. 7, Elsevier, Paris, pp. 1-17.
37. Schmidt-Kastner, R., Paschen, W., Ophoff, B. G., and Hossmann, K. A. (1989). A modified four vessel occlusion model for inducing incomplete forebrain ischemia in rats. Stroke 20:938-946.
38. Seif-El-Nasr, M., and El-Fattah, A. A. (1995). Lipid peroxide, phospholipids, glutathione levels and superoxid dismutase activity in rat brain after ischemia: Effects of Ginkgo biloba extract. Pharmacol. Res. 32:273-278.
39. Shen, J. G., and Zhou, D. Y. (1995). Efficiency of Ginkgo biloba extract (EGb 761) in antioxidant protection against myocardial ischemia and reperfusion injury. Biochem. Mol. Biol. Int. 35:125-134.
40. Spinnewyn, B., Blavet, N., and Clostre, F. (1986). Effects of Ginkgo biloba extract on a cerebral ischemia model in gerbils. Presse Méd. 15:1511-1515.
41. Swanson, R. A., Ying, W., and Kauppinen, T. M. (2004). Astrocyte influences on ischemic neuronal death. Curr. Mol. Med. 4:193-205.
42. Westman, J., Drieu, K., and Sharma, H. S. (2000). Antioxidant compounds EGb-761 and BN-520 21 attenuate heat shock protein (HSP 72 kD) response, edema and cell changes following hyperthermic brain injury. An experimental study using immunohistochemistry in the rat. Amino Acids 19:339-350.
43. Zhang, W. R., Hayashi, T., Kitagawa, H., Sasaki, C., Sasaki, K., Warita, H., Wang, J. M., Shiro, Y., Uchida, M., and Abe, K. (2000). Protective effect of Ginkgo extract on rat brain with transient middle cerebral artery occlusion. Neurol. Res. 22:517-521.